Yang‐Min Ning
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Behavioral Neuroscience top 5%
Papers in
-
- Prostate Cancer Treatment and Research 13
- Renal cell carcinoma treatment 4
- Oncology 14
- Cancer Immunotherapy and Biomarkers 9
- Cancer Treatment and Pharmacology 4
- Co-authors
- Edwin R. Sánchez (5 shared papers)Richard Pazdur (14 shared papers)Robert Justice (5 shared papers)William L. Dahut (11 shared papers)V. Ellen Maher (11 shared papers)Shenghui Tang (8 shared papers)Patricia Keegan (2 shared papers)Rajeshwari Sridhara (8 shared papers)
- Journals
- Journal of Clinical Oncology (15 papers)Clinical Cancer Research (3 papers)The Oncologist (3 papers)Therapeutic Innovation & Regulatory Science (2 papers)Biochemistry (2 papers)
- Partner nations
- United StatesNetherlands
In The Last Decade
Yang‐Min Ning
37 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 116
- Oncology 777
- Behavioral Neuroscience 97
- Pulmonary and Respiratory Medicine 535
- Cancer Research 240
- Immunology 350
Countries citing papers authored by Yang‐Min Ning
This map shows the geographic impact of Yang‐Min Ning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang‐Min Ning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang‐Min Ning more than expected).
Fields of papers citing papers by Yang‐Min Ning
This network shows the impact of papers produced by Yang‐Min Ning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang‐Min Ning. The network helps show where Yang‐Min Ning may publish in the future.
Co-authors
The 25 scholars most cited alongside Yang‐Min Ning, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 346 | |
| 2 | 2019 | 235 | |
| 3 | 2010 | 201 | |
| 4 | 2005 | 156 | |
| 5 | 2011 | 155 | |
| 6 | 2018 | 141 | |
| 7 | 2010 | 114 | |
| 8 | 2017 | 113 | |
| 9 | 2011 | 106 | |
| 10 | 2009 | 106 | |
| 11 | 2011 | 98 | |
| 12 | 1993 | 67 | |
| 13 | 2018 | 52 | |
| 14 | 2013 | 49 | |
| 15 | Liposomal doxorubicin in combination with bortezomib for relapsed or refractory multiple myeloma. | 2007 | 48 |
| 16 | 2013 | 39 | |
| 17 | 2017 | 36 | |
| 18 | 2015 | 36 | |
| 19 | 2014 | 31 | |
| 20 | 1995 | 28 |
About Yang‐Min Ning
Yang‐Min Ning is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Molecular Biology and Hematology, having authored 37 papers that have together received 2.3k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (13 papers), Bladder and Urothelial Cancer Treatments (12 papers), Cancer Immunotherapy and Biomarkers (9 papers), Multiple Myeloma Research and Treatments (6 papers), Heat shock proteins research (5 papers), Signaling Pathways in Disease (5 papers), Renal cell carcinoma treatment (4 papers) and Cancer Treatment and Pharmacology (4 papers). The work is most often cited by research in Oncology (777 citations), Behavioral Neuroscience (97 citations), Pulmonary and Respiratory Medicine (535 citations), Cancer Research (240 citations) and Immunology (350 citations). Yang‐Min Ning has collaborated with scholars based in United States and Netherlands. Frequent co-authors include Edwin R. Sánchez, Richard Pazdur, Robert Justice, William L. Dahut, V. Ellen Maher, Shenghui Tang, Patricia Keegan, Rajeshwari Sridhara, William D. Figg and James L. Gulley. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, The Oncologist, Therapeutic Innovation & Regulatory Science and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.